Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4281949
Max Phase: Preclinical
Molecular Formula: C25H28O6
Molecular Weight: 424.49
Molecule Type: Small molecule
Associated Items:
ID: ALA4281949
Max Phase: Preclinical
Molecular Formula: C25H28O6
Molecular Weight: 424.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=C2\CCC/C(=C\c3cc(OC)c(OC)c(OC)c3)C2=O)cc1OC
Standard InChI: InChI=1S/C25H28O6/c1-27-20-10-9-16(13-21(20)28-2)11-18-7-6-8-19(24(18)26)12-17-14-22(29-3)25(31-5)23(15-17)30-4/h9-15H,6-8H2,1-5H3/b18-11+,19-12+
Standard InChI Key: PBLBDHMOTVYVRV-GDAWTGGTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 424.49 | Molecular Weight (Monoisotopic): 424.1886 | AlogP: 4.95 | #Rotatable Bonds: 7 |
Polar Surface Area: 63.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.81 | CX LogD: 4.81 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.59 | Np Likeness Score: -0.06 |
1. Leong SW, Chia SL, Abas F, Yusoff K.. (2018) Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro., 157 [PMID:30138803] [10.1016/j.ejmech.2018.08.039] |
2. Leong SW, Chia SL, Abas F, Yusoff K.. (2020) Synthesis and in-vitro anti-cancer evaluations of multi-methoxylated asymmetrical diarylpentanoids as intrinsic apoptosis inducer against colorectal cancer., 30 (8): [PMID:32127259] [10.1016/j.bmcl.2020.127065] |
Source(1):